SubscribeLogin
Cardiovascular News image

News from Cardiovascular News

We’ve assigned a rating of Unknown factuality to Cardiovascular News. You can read more about how we’ve determined Cardiovascular News’s credibility and reliability as a news source here: https://ground.news/rating-system.

Information about Cardiovascular News

Where is Cardiovascular News located?Cardiovascular News's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Average Factuality Rating:
Learn more about Factuality Ratings.

Top Cardiovascular News News

Early valve replacement falls short in EVOLVED trial - Cardiovascular News
Washington DC · Washington

Early valve replacement falls short in EVOLVED trial - Cardiovascular News

Mark Dweck The question of early intervention among patients with severe aortic stenosis but no symptoms stood at the heart of two of the most significant trials presented at TCT 2024 (27–30 October, Washington, DC, USA). If EARLY TAVR prompted some to conclude that, instead of waiting for aortic stenosis symptoms to progress, physicians now have the evidence to justify an early intervention through transcatheter aortic valve implantation (TAVI)…See the Story
Orbital atherectomy fails to eclipse balloon angioplasty in randomised trial in severely calcified lesions
New York State · New York

Orbital atherectomy fails to eclipse balloon angioplasty in randomised trial in severely calcified lesions

Ajay Kirtane The routine use of orbital atherectomy prior to percutaneous coronary intervention (PCI) in severely calcified lesions does not improve outcomes compared to conventional balloon angioplasty, findings of the ECLIPSE clinical trial have shown. The large-scale trial, that enrolled more than 2,000 patients at over 100 sites throughout the USA, showed that the two strategies were similar for a primary clinical endpoint of target vessel f…See the Story
Trilogy valve shows favourable results at two years in aortic regurgitation patients - Cardiovascular News
New York State · New York

Trilogy valve shows favourable results at two years in aortic regurgitation patients - Cardiovascular News

Torsten Vahl presents at TCT 2024 Latest data from the ALIGN AR trial, investigating the use of the Trilogy (JenaValve) transcatheter aortic valve implantation (TAVI) system in high-risk patients with symptomatic, severe aortic regurgitation, support the safety and efficacy of the device out to two years. Torsten Vahl (NewYork-Presbyterian/ Columbia University Medical Center, New York, USA) presented two-year outcomes from the trial—a landmark p…See the Story

Latest News Stories

You've scrolled to the bottom of the feed, there are no more stories.
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal